Table 2.
N = 376 | Total Cohort (N = 376) |
TTE-IMV (N = 223) |
TTE-bIMV (N = 68) |
TTE-aIMV (N = 85) |
p-Value 1 |
---|---|---|---|---|---|
RV GLS | |||||
Median (Q1–Q3) | 19.0 (13.5–24.7) | 15.9 (10.6–20.8) | 22.3 (19.3–22.3) | 23.8 (19.8–27.0) | <0.001 |
TAPSE (mm) | (n = 295) | (n = 163) | (n = 57) | (n = 75) | |
Median (Q1–Q3) | 20 (16.1–23.7) | 18.1 (15.4–21.6) | 21.6 (17.3–24.1) | 22.9 (19.4–25.2) | <0.001 |
RV FWLS | |||||
Median (Q1–Q3) | 23.2 (16.6–28.7) | 19.7 (14.0–25.8) | 25.5 (21.4–32.0) | 27.7 (22.9–31.8) | <0.001 |
RV FAC | (n = 313) | (n = 160) | (n = 68) | (n = 85) | |
Median (Q1–Q3) | 46.7 (37.9–55.1) | 51.3 (42.0–59.9) | 40.8 (34.9–49.6) | 44.1 (36.4–51.9) | <0.001 |
1 Wilcoxon rank-sum.